Recovery From ICUAW Following Severe Respiratory and Cardiac Failure
Recruiting · NCT03753412 · Observational (researchers observe without assigning treatment) · Lead sponsor: Barts & The London NHS Trust
View the official record on ClinicalTrials.gov →What this trial is about
To observe and identify determinants of recovery from intensive care unit-acquired weakness (ICUAW) following a severe cardiorespiratory failure requiring extra-corporeal membrane oxygenation (ECMO). Additionally, to discover the effects of ICUAW on physical function and health-related quality of life (HRQoL) after critical illness. CLEVERER is a clinical observational pilot study.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Above the age of 18
- Adults with severe cardio-respiratory failure requiring ECMO.
- Adults who have had personal and professional consultees agree to enrol them in the trial.
Exclusion criteria
- Previous Stroke
- Neuromuscular disease
- Malignancy
- Underlying neuromuscular disease
- paediatrics
Where it is running
1 location listed.
- St Bartholomew's hospital (Barts NHS trust) - London, United Kingdom